About WD repeat and FYVE domain-containing protein 1
WD repeat and FYVE domain-containing protein 1 (WDFY1) is a protein
from Homo sapiens identified by UniProt accession
Q8IWB7, 410 residues long.
MolForge cross-references it against 0 known binders and
101 disease associations.
Target properties
| Protein name | WD repeat and FYVE domain-containing protein 1 |
| UniProt accession | Q8IWB7 |
| Gene | WDFY1 |
| Organism | Homo sapiens |
| Length | 410 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (101)
Diseases linked to this target (Open Targets).
- Red cell distribution width · score 0.41
- Parkinson disease · score 0.21
- multiple sclerosis · score 0.21
- Alzheimer disease · score 0.21
- neurodegenerative disease · score 0.21
- lysosomal storage disease · score 0.21
- platelet-derived growth factor BB measurement · score 0.12
- Brugada syndrome · score 0.07
- Romano-Ward syndrome · score 0.07
- Arrhythmogenic right ventricular dysplasia · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8IWB7-F1 | alphafold | PREDICTED | 92.08 | — |
Amino-acid sequence (410 residues)
MAAEIHSRPQ SSRPVLLSKI EGHQDAVTAA LLIPKEDGVI TASEDRTIRV WLKRDSGQYW PSIYHTMASP CSAMAYHHDS RRIFVGQDNG AVMEFHVSED FNKMNFIKTY PAHQNRVSAI IFSLATEWVI STGHDKCVSW MCTRSGNMLG RHFFTSWASC LQYDFDTQYA FVGDYSGQIT LLKLEQNTCS VITTLKGHEG SVACLWWDPI QRLLFSGASD NSIIMWDIGG RKGRTLLLQG HHDKVQSLCY LQLTRQLVSC SSDGGIAVWN MDVSREEAPQ WLESDSCQKC EQPFFWNIKQ MWDTKTLGLR QHHCRKCGQA VCGKCSSKRS SYPVMGFEFQ VRVCDSCYDS IKDEDRTSLA TFHEGKHNIS HMSMDIARGL MVTCGTDRIV KIWDMTPVVG CSLATGFSPH
Explore WD repeat and FYVE domain-containing protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets